( India could make her own generic drug v...)India to produce Tamiflu generic ‘Oseltamivir,Health
Navigation Links
India to produce Tamiflu generic ‘Oseltamivir
India could make her own generic drug version of the Tamiflu anti-flu drug. Roche who holds the patent for Tamiflu drug his under great international pressure from different government agencies for the right to manufacture // generic drugs as most of the developing and under-developed countries could not afford the drug. The new generic version of Tamiflu ‘Oseltamivir’ is to be manufactured by Hetero drug.
'"/>
Related medicine news :
1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
(Date:12/4/2009).... 4 , ,What: Humana ( ht... health benefits provider, is introd...s.com ), a senior-friendly dance pad, ...ues., Dec. 8 at 1 p.m. The festive ...n to the public, will feature Dancetown, ...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- MedClean Technologies, In...Company has entered into a preferred stock purchas...ware limited liability company, doing business as... to the Purchase Agreement, MedClean will receive ...agreed to sell up to 750 shares of its Series C Pr...
(Date:12/4/2009)...Newswire/ -- PLUS Diagnostics announced today th...y services with the launch of a national hematolog... company,s expansion from a regional laboratory to...ering diagnostic services across a full range of s... now hematology/oncology. ,, PLUS Diagnostics ...
(Date:12/4/2009)...RNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc...5,012,334 for the first quarter ended September 30...ear. Operating income and net income for the quar...a 70% decrease over the same period last year. ,... sector sales. This trend is expected to continue...
(Date:12/4/2009)...swire/ -- The National Cancer Institute has awarde...Hutchinson Cancer Research Center to become the na...vice Contact Center. ,, The move will create 60...ng the size of its current CIS workforce - once th...is scheduled for March 15, 2010. The Seattle CIS c...
Breaking Medicine News(10 mins):Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 2Health News:MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million 3Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2[0] Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee[0] MedClean Technologies Enters Into Preferred Stock Agreement of Up to $7.5 Million[0] PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services[0] PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings[0] Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service
...d problems of Social Security based on the Social ...y misplaced," asserts former U.S. House Aging Comm...hief of Staff of the House Aging Committee under R...as already absorbed eleven ,deficit, years since 1...
...ls, Inc. (Nasdaq: ONXX ) today announced that it...lth Care Conference on Tuesday, May 19, at 2:35 p....live webcast of the presentation on our website at...download any necessary software. For those unable...
...ct, researchers note , , TUESDAY, May 12 (...es to tell whether aspirin reduces the risk of hea...g blood vessel condition called peripheral arteria...n use with peripheral arterial disease (PAD); it a...
..., it,s meant orthotics and physical therapy so he ...ebecca, it,s an insulin pump for her Type 1 Diabet...lsy, it,s a wheelchair. , , All these children an...perately needed medical care or equipment. , , UH...
...ecisions When Choosing Nutritional Products , , A...eroid use in sports continue to emphasize the impo... nutrition products for banned substances. , , (...improving public health, has launched a new online...
...l gather in New Orleans on June 18 to share inform...y damage controversy involving building materials:...ering for two teleconferences dealing with the ins...nd the District of Columbia have reported "health ...
Other Medicine News:Health News:Social Security 'Problems' Are 'Misplaced Scare Tactics' and Media Missing Story of Solvency, Says Former Congressional Aging Committee Chief of Staff Bob Weiner 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:New Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned Substances 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Social Security 'Problems' Are 'Misplaced Scare Tactics' and Media Missing Story of Solvency, Says Former Congressional Aging Committee Chief of Staff Bob WeinerOnyx Pharmaceuticals to Present at the Deutsche Bank 34th Annual Health Care ConferenceAspirin Lowers Stroke Risk in Peripheral Artery DiseaseUnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New JerseyNew Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned SubstancesChinese Drywall Litigation Subject of Conference and Two Teleconferences
(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2[0] MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009[0] Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up[0] Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
...ONTO, Feb. 15 A seven-year, international,study p...es such as,acupuncture, neck manipulation and mass...ck pain than many current practices. Also included...exercises, education, neck,mobilization, low level...h as neck collars and ultrasound are not recommend...
...TH SAN FRANCISCO, Calif., Feb. 15 Cell,Genesys, I...an analysis,examining the potential association be...rostate cancer and increased patient survival in a...e refractory prostate cancer,(HRPC). More than 400...were,identified in the sera of the treated patient...
Other Medicine Technology:Seven-Year Neck Pain Study Sheds Light on Best Care 2Seven-Year Neck Pain Study Sheds Light on Best Care 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 4Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |